Found: 48
Select item for more details and to access through your institution.
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 775, doi. 10.1002/ajh.25818
- By:
- Publication type:
- Article
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.234443
- By:
- Publication type:
- Article
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 4, p. 601, doi. 10.1111/bjh.15585
- By:
- Publication type:
- Article
cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0205135
- By:
- Publication type:
- Article
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 4, p. 583, doi. 10.1111/bjh.14451
- By:
- Publication type:
- Article
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 788, doi. 10.1111/bjh.13773
- By:
- Publication type:
- Article
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status.
- Published in:
- 2015
- By:
- Publication type:
- journal article
α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After <sup>211</sup>At-Radioimmunotherapy for Hematopoietic Cell Transplantation.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 11, p. 1766, doi. 10.2967/jnumed.115.162388
- By:
- Publication type:
- Article
Mechanisms and clinical applications of chromosomal instability in lymphoid malignancy.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 1, p. 13, doi. 10.1111/bjh.13507
- By:
- Publication type:
- Article
Radioimmunotherapy of human tumours.
- Published in:
- Nature Reviews Cancer, 2015, v. 15, n. 8, p. 509, doi. 10.1038/nrc3987
- By:
- Publication type:
- Article
Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera.
- Published in:
- Medical Physics, 2015, v. 42, n. 7, p. 4094, doi. 10.1118/1.4921997
- By:
- Publication type:
- Article
Stable and Efficient Paclitaxel Nanoparticles for Targeted Glioblastoma Therapy.
- Published in:
- Advanced Healthcare Materials, 2015, v. 4, n. 8, p. 1236, doi. 10.1002/adhm.201500034
- By:
- Publication type:
- Article
Radioimmunotherapy of human tumours.
- Published in:
- Nature Reviews Cancer, 2015, v. 15, n. 6, p. 347, doi. 10.1038/nrc3925
- By:
- Publication type:
- Article
Radioimmunotherapy of human tumours.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Intracellular Delivery System for Antibody-Peptide Drug Conjugates.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 5, p. 907, doi. 10.1038/mt.2015.22
- By:
- Publication type:
- Article
Comparative Efficacy of <sup>177</sup>Lu and <sup>90</sup>Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120561
- By:
- Publication type:
- Article
Anti-CD45 Radioimmunotherapy with <sup>90</sup>Y but Not <sup>177</sup>Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0113601
- By:
- Publication type:
- Article
R- CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma ( DLBCL): SWOG S0433.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 382, doi. 10.1111/bjh.12906
- By:
- Publication type:
- Article
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 358, doi. 10.1111/bjh.12753
- By:
- Publication type:
- Article
Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082742
- By:
- Publication type:
- Article
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide ( ICE) in patients with relapsed lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 2, p. 183, doi. 10.1111/bjh.12230
- By:
- Publication type:
- Article
Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.
- Published in:
- Advances in Hematology, 2012, p. 1, doi. 10.1155/2012/932658
- By:
- Publication type:
- Article
Anti-CD22 Antibody Targeting of pH-responsive Micelles Enhances Small Interfering RNA Delivery and Gene Silencing in Lymphoma Cells.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 8, p. 1529, doi. 10.1038/mt.2011.104
- By:
- Publication type:
- Article
Six of 12 Relapsed or Refractory Indolent Lymphoma Patients Treated 10 Years Ago with <sup>131</sup>I-Tositumomab Remain in Complete Remission.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 6, p. 896, doi. 10.2967/jnumed.111.087460
- By:
- Publication type:
- Article
Improving the Efficacy of Radioimmunotherapy for Non-Hodgkin Lymphomas.
- Published in:
- Cancer (0008543X), 2010, v. 116, p. 1126
- By:
- Publication type:
- Article
Improving the efficacy of radioimmunotherapy for non-Hodgkin lymphomas.
- Published in:
- 2010
- By:
- Publication type:
- journal article
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma.
- Published in:
- Oncologist, 2008, v. 13, n. 6, p. 657, doi. 10.1634/theoncologist.2008-0020
- By:
- Publication type:
- Article
Myeloablative <sup>131</sup>I-Tositumomab Radioimmunotherapy in Treating Non-Hodgkin's Lymphoma: Comparison of Dosimetry Based on Whole-Body Retention and Dose to Critical Organ Receiving the Highest Dose.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 5, p. 837, doi. 10.2967/jnumed.107.043190
- By:
- Publication type:
- Article
53. Preliminary Results of a Pilot Phase I Clinical Trial of Adoptive Immunotherapy for B Cell Lymphoma Using CD8+ T Cells Genetically Modified To Express a Chimeric T Cell Receptor Recognizing CD20.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S22, doi. 10.1016/j.ymthe.2006.08.068
- By:
- Publication type:
- Article
High-Dose <sup>131</sup>I-Tositumomab (Anti-CD20) Radioimmunotherapy for Non-Hodgkin's Lymphoma: Adjusting Radiation Absorbed Dose to Actual Organ Volumes.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 6, p. 1059
- By:
- Publication type:
- Article
Cellular Immunotherapy for Follicular Lymphoma Using Genetically Modified CD20-Specific CD8<sup>+</sup> Cytotoxic T Lymphocytes
- Published in:
- Molecular Therapy, 2004, v. 9, n. 4, p. 577, doi. 10.1016/j.ymthe.2003.12.011
- By:
- Publication type:
- Article
Comparison of Immunoscintigraphy, Efficacy, and Toxicity of Conventional and Pretargeted Radioimmunotherapy in CD20-Expressing Human Lymphoma Xenografts.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 3, p. 437
- By:
- Publication type:
- Article
Emerging immunotherapies for non-Hodgkin lymphomas: the tortoise approaches the finish line.
- Published in:
- 2000
- By:
- Publication type:
- editorial
Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas.
- Published in:
- International Journal of Cancer, 2000, v. 85, n. 1, p. 104, doi. 10.1002/(SICI)1097-0215(20000101)85:1<104::AID-IJC19>3.0.CO;2-G
- By:
- Publication type:
- Article
Post therapy imaging in high dose I-131 radioimmunotherapy patients.
- Published in:
- Medical Physics, 1994, v. 21, n. 7, p. 1157, doi. 10.1118/1.597343
- By:
- Publication type:
- Article
Localized beta dosimetry of 131I -labeled antibodies in follicular lymphoma.
- Published in:
- Medical Physics, 1992, v. 19, n. 1, p. 97, doi. 10.1118/1.596932
- By:
- Publication type:
- Article
Imaging and Treatment of B-Cell Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 1990, v. 31, n. 8, p. 1257
- By:
- Publication type:
- Article
Evaluation and management of chylous ascites.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Anti-Brain Antisera Bind Primarily to Non-T Cells in Mouse Bone Marrow<sup>1</sup>.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1977, v. 156, n. 3, p. 485, doi. 10.3181/00379727-156-39962
- By:
- Publication type:
- Article